Navigation Links
San Antonio Breast Cancer Symposium December 13th to 16th 2007
Date:12/10/2007

SAN ANTONIO, Dec. 10 /PRNewswire-USNewswire/ -- For the past 30 years, the San Antonio Breast Cancer Symposium has been a forum of interaction and exchange among scientists and clinicians from around the world, for breast cancer research. It is an educational milieu providing an ideal format for scientists to present, for the first time, new and late breaking data, as well as other pertinent information, including diagnostic developments.

The symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease. The scientific program consists of invited lectures and mini-symposia by experts in clinical and basic research; selected slide and poster presentations chosen from submitted abstracts; and case discussions. General sessions are 2-3 hours in duration and are the vehicle for slide presentations, each of which is allotted 10 minutes, followed by 5 minutes of discussion. Each poster session lasts 2 hours.

Approximately 8300 registrants are expected at this year's symposium; the majority of whom are physicians and researchers from more than 80 countries, (including the US and Canada), with smaller representation by affiliated health care professionals.

For all that has been discovered since we started this meeting 30 years ago, much remains to be done. We are still only beginning to unlock the secrets of breast cancer biology that we expect will lead to more effective individualized treatments. Ongoing developments in existing therapies continue to refine our ability to discover very early-stage disease and to whittle away at breast cancer-related mortality. This year at the San Antonio Breast Cancer Symposium, 5 renowned experts will present reviews and updates about multidisciplinary breast cancer treatment; the exciting area of insulin regulation and its role in breast cancer development; and the important but frequently overlooked field of symptom management. Four mini-symposia will provide expert discussion on breast cancer stem cells; developments from the Women's Health Initiative; molecular imaging; and a systems biology approach to studying the HER network. This year, there will be over 700 poster presentations highlighting new research that may lead to the critical developments of the future.

The San Antonio Breast Cancer Symposium is a collaborative effort of the San Antonio Cancer Institute and Baylor College of Medicine. The San Antonio Cancer Institute, an NCI-designated clinical cancer center, is a partnership of the Cancer Therapy and Research Center and The University of Texas Health Science Center at San Antonio.


'/>"/>
SOURCE San Antonio Breast Cancer Symposium
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio
2. October 18 Rally - San Antonio - to Protest Attack on Medical Benefits By AT&T Corporation
3. Pelosi, Members of Texas Delegation to Rally for Childrens Health Care in San Antonio Tomorrow
4. Mayor Antonio Villaraigosa Partners With AltaMed Health Services to Launch City of Los Angeles HIV Testing Initiative
5. Digital Healthcare Announces MacGregor Medical Center San Antonio to Utilize Retasure for Retinal Imaging Assessment
6. New Taxotere(R) (docetaxel) Injection Concentrate Data to be Presented at the 30th Annual San Antonio Breast Cancer Symposium (SABCS)
7. Survival differences by race most apparent in advanced stages of breast cancer
8. MRI finds breast cancer before it becomes dangerous
9. Pathway links inflammation, angiogenesis and breast cancer
10. Drop in breast cancer incidence linked to hormone use, not mammograms
11. Breast cancer prevention practices vary across Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... Raton (PRWEB) , ... September 19, 2017 , ... ... the El Naturalista brand, developed by ACPG Laboratories, is coming soon to RonnieColemanNutrition.com. ... in Spain, and El Naturalista is a trusted, well-respected brand reliant on the ...
(Date:9/19/2017)... ... ... For decades doctors, nurses, and other healthcare providers have been trained to ... calculating their cardiovascular disease (CVD) risk in the next 10 years. , Imagine ... an estimated 10-year risk prediction! , Imagine if the weatherman says there is a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... with the Davidson Fellows Scholarship on September 27 at a reception in Washington ... Technology, Engineering, Mathematics, Literature and Music. , “I am honored to be a ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency nursing expertise, skill ... Emergency Nurse (CEN®) certification according to a large-scale study announced today by ... conducted by the Human Resources Research Organization (HumRRO) in late 2016 and early ...
(Date:9/18/2017)... Bangkok, Thailand (PRWEB) , ... September 19, 2017 ... ... in Asia Pacific’s protein ingredient market , expected to grow at the ... Frost & Sullivan sharing the ‘Global Food Protein Trends & Growth Opportunities in ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic storage ... Mike Rice , President and CEO, will be presenting ... Rodman & Renshaw 19 th Annual Global Investment ... (12:25 p.m. Pacific time). The conference is being held at ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
Breaking Medicine Technology: